Kontigo Care (Q3 Initial take): Back to sequential growth - Redeye

Redeye provides an initial take on Kontigo Care’s Q3 2025 results. Sales, MRR, and EBIT were broadly in line with expectations, while a lower cost base and reduced capitalisations offset each other at the EBIT level. The key highlight is that both sales and MRR increased q/q, with additional upside expected from secured contracts. Only minor estimate revisions are expected.

Länk till analysen i sin helhet: https://www.redeye.se/research/1135090/kontigo-care-q3-initial-take-back-to-sequential-growth?utm_source=finwire&utm_medium=RSS